BioCentury
ARTICLE | Company News

NanoViricides infectious news

March 10, 2014 7:00 AM UTC

Infectious disease company NanoViricides denied a rumor from a blog post on investment news website Seeking Alpha that the company is being acquired for up to $4.5 billion. In a statement, NanoViricides said it has not had any discussions of such nature. The blog cited a source close the matter who is "intent on acquiring NanoViricides for defensive purposes." ...